Gaurav Dhapola

PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial

Tanya B. Dorff, M. Suzette Blanchard, Lauren Adkins et al. · Nature Medicine · 2024 · 116 citations · Full text

Medicine, Immunology, Oncology +17

Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting

Eric Hee Jun Lee, John P. Murad, Lea Christian et al. · Nature Communications · 2023 · 102 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase 1 study of PSCA-targeted chimeric antigen receptor (CAR) T cell therapy for metastatic castration-resistant prostate cancer (mCRPC).

Tanya B. Dorff, Suzette Blanchard, Hripsime Martirosyan et al. · Journal of Clinical Oncology · 2022 · 19 citations

Medicine, Immunology, Oncology +17

Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting

Eric Hee Jun Lee, Cody Cullen, John P. Murad et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2023 · 11 citations · Full text

Life Sciences, Immunology, Oncology +17

Final results from phase I study of PSCA-targeted chimeric antigen receptor (CAR) T cells in patients with metastatic castration resistant prostate cancer (mCRPC).

Tanya B. Dorff, Suzette Blanchard, Hripsime Martirosyan et al. · Journal of Clinical Oncology · 2023 · 10 citations

Medicine, Oncology, Pharmacology +17